"The evolution of the definition for high-risk multiple myeloma will help identify patients ... monoclonal protein ≥500 mg per 24 h and/or clonal BMPCs 10-60% Absence of MDEs or amyloidosis ...

Clonal hematopoiesis of indeterminate potential is a possible biomarker of CVD risk in patients with multiple myeloma who are undergoing hematopoietic cell transplant. A secondary analysis of the ...

Researchers have demonstrated the potential of the innovative optical genome mapping (OGM) technique for the diagnosis, ...

"The evolution of the definition for high-risk multiple myeloma will help identify patients with light chain cast nephropathy, which is a key myeloma defining event for symptomatic multiple ...